帕金森病的手术治疗方法
Ariane Veilleux Carpentier1, Michael S Okun2
1Centre Hospitalier de l'Université de Montréal, 1000 rue St-Denis, Montréal, Québec, Canada.
Neurologic clinics
|April 4, 2025
概括
帕金森病的手术选择在药物失败时提供了替代方案. 个性化治疗计划和多学科护理是帕金森病患者最佳外科治疗结果的关键.
科学领域:
- 神经学 神经学
- 神经外科 神经外科
- 运动障碍 运动障碍
背景情况:
- 帕金森病 (PD) 的管理往往需要除了药物之外的干预措施.
- 对于药物治疗治疗反应不足的患者来说,手术治疗至关重要.
- 不断发展的外科手术技术需要更新帕金森病的治疗模式.
研究的目的:
- 审查目前对帕金森病的手术干预措施.
- 突出个性化治疗选择和多学科护理的重要性.
- 讨论帕金森病手术治疗的不断变化的格局.
主要方法:
- 对帕金森病的废除技术的审查.
- 对帕金森病的深度脑刺激 (DBS) 的分析.
- 对莱沃多巴-卡比多巴肠凝和皮下输送的输液和系统的评估.
主要成果:
- 不同的手术选择,包括除技术和深度大脑刺激,具有明显的好处和缺点.
- 连续输液系统 (莱沃多巴-卡比多巴肠凝和皮下) 提供了替代的输送方法.
- 个性化患者选择和多学科评估对于成功的手术干预至关重要.
结论:
- 在医疗治疗不足时,手术干预对于管理晚期帕金森病至关重要.
- 个性化的方法,考虑到患者特定的因素,对于选择最有效的外科治疗是必不可少的.
- 持续的随访是必要的,以优化治疗疗效和手术治疗帕金森病患者的潜在并发症的管理.
相关概念视频
Parkinson's Disease: Treatment
163
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
163
Parkinson's Disease: Overview
360
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
360
Alzheimer's Disease: Treatment
134
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
134
Psychosurgery
29
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
29
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
Skeletal Muscle Relaxants: Therapeutic Uses
444
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
444


